ITMI991503A0 - Uso di metaboliti oligosaccaridici di proteoglicani come maker in flui di biologici di diagnosi del biabete e delle complicanze patologiche c - Google Patents

Uso di metaboliti oligosaccaridici di proteoglicani come maker in flui di biologici di diagnosi del biabete e delle complicanze patologiche c

Info

Publication number
ITMI991503A0
ITMI991503A0 IT99MI001503A ITMI991503A ITMI991503A0 IT MI991503 A0 ITMI991503 A0 IT MI991503A0 IT 99MI001503 A IT99MI001503 A IT 99MI001503A IT MI991503 A ITMI991503 A IT MI991503A IT MI991503 A0 ITMI991503 A0 IT MI991503A0
Authority
IT
Italy
Prior art keywords
flues
proteoglycans
makers
belief
oligosaccharide
Prior art date
Application number
IT99MI001503A
Other languages
English (en)
Inventor
Ivo Volpato
Giovanni Scapagnini
Flavio Veneroni
Bernard Bizzini
Lorenzo Volpato
Maurizio Magara
Original Assignee
Bidifarm S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bidifarm S R L filed Critical Bidifarm S R L
Priority to IT1999MI001503A priority Critical patent/ITMI991503A1/it
Publication of ITMI991503A0 publication Critical patent/ITMI991503A0/it
Priority to EP00949290A priority patent/EP1198709A1/en
Priority to PCT/EP2000/006474 priority patent/WO2001004632A1/en
Priority to AU62706/00A priority patent/AU6270600A/en
Publication of ITMI991503A1 publication Critical patent/ITMI991503A1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IT1999MI001503A 1999-07-08 1999-07-08 Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c ITMI991503A1 (it)

Priority Applications (4)

Application Number Priority Date Filing Date Title
IT1999MI001503A ITMI991503A1 (it) 1999-07-08 1999-07-08 Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c
EP00949290A EP1198709A1 (en) 1999-07-08 2000-07-07 Glycosaminoglycan metabolites in diabetes diagnosis and treatment
PCT/EP2000/006474 WO2001004632A1 (en) 1999-07-08 2000-07-07 Oligosaccharide metabolites of glycosaminoglycans and their use in the diagnosis and treatment of complications of diabetes
AU62706/00A AU6270600A (en) 1999-07-08 2000-07-07 Oligosaccharide metabolites of glycosaminoglycans and their use in the diagnosisand treatment of complications of diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1999MI001503A ITMI991503A1 (it) 1999-07-08 1999-07-08 Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c

Publications (2)

Publication Number Publication Date
ITMI991503A0 true ITMI991503A0 (it) 1999-07-08
ITMI991503A1 ITMI991503A1 (it) 2001-01-08

Family

ID=11383300

Family Applications (1)

Application Number Title Priority Date Filing Date
IT1999MI001503A ITMI991503A1 (it) 1999-07-08 1999-07-08 Uso di metaboliti oligosaccaridici di proteoglicani come maker in fluidi biologici di diagnosi del biabete e delle complicanze patologiche c

Country Status (4)

Country Link
EP (1) EP1198709A1 (it)
AU (1) AU6270600A (it)
IT (1) ITMI991503A1 (it)
WO (1) WO2001004632A1 (it)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1274351B (it) * 1994-10-06 1997-07-17 Alfa Wassermann Spa Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
US6150115A (en) * 1997-04-04 2000-11-21 Seikagaku Kogyo Kabushiki Kaisha Quantitative determination method for heparan sulfate and diagnostic method using the same
DE19747195A1 (de) * 1997-10-24 1999-04-29 Knoll Ag Verwendung von Glykosaminoglykanen zur Herstellung von pharmazeutischen Zubereitungen zur Behandlung von mit Diabetes assoziierten Augenkrankheiten
IT1299969B1 (it) * 1998-04-15 2000-04-04 Alfa Wassermann Spa Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.

Also Published As

Publication number Publication date
EP1198709A1 (en) 2002-04-24
ITMI991503A1 (it) 2001-01-08
WO2001004632A1 (en) 2001-01-18
AU6270600A (en) 2001-01-30

Similar Documents

Publication Publication Date Title
HK1146725A1 (en) Thioflavin derivatives for use in the diagnosis of alzheimers disease
IL177847A0 (en) Use of lipid conjugates in the treatment of disease
IL150628A0 (en) Use of lipid conjugates in the treatment of disease
DK1031346T3 (da) Ikke-invasiv vaccination gennem huden
NO20014769L (no) Preparat for behandling og diagnostikk av brystcancer og fremgangsmater for anvendelse derav
DE50011194D1 (de) Medizinisches Instrument zum Präparieren von Gewebe
PL1641918T3 (pl) Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia
IL175186A0 (en) Three-dimensional cardiac imaging using ultrasound contour reconstruction
PL1979050T3 (pl) Leczenie chorób naczyń obwodowych z zastosowaniem komórek pochodzenia poporodowego
IL187220A (en) Use of sodium arsenite sodium in the preparation of a drug for the treatment of metastatic tumor diseases
EP1633379A4 (en) COMPOSITION OF BAMBOO EXTRACT AND CORROSIVE COMPOUNDS WITH TREATMENT AND PREVENTIVE EFFECT FOR INFLAMMATORY DISEASES AND BLEACHING DISEASES
EP1459759A4 (en) MEDICAMENT FOR THE MOBILIZATION OF PLURIPOTENTIAL STEM CELLS FROM TISSUE IN THE PERIPHERAL BLOOD
IL190841A0 (en) Pharmaceutical compositions and diagnostic methods for inflammatory skin diseases, disorders or conditions
DE60125319D1 (de) Wellenfrontrefraktor zur gleichzeitigen aufnahme zweier hartmann-shack-bilder
IL183227A0 (en) Use of lipid conjugates in the treatment of disease
ITMI991503A0 (it) Uso di metaboliti oligosaccaridici di proteoglicani come maker in flui di biologici di diagnosi del biabete e delle complicanze patologiche c
GB2411834B (en) Composition for use in the treatment of dry skin conditions
DE69929389D1 (de) Nichtinvasiver Blutdruckwächter
AU2001283199A1 (en) Methods and compositions for the diagnosis and treatment of brown adipose cell disorders
AU2001285026A1 (en) Methods and compositions for use in the diagnosis and treatment of chronic immune disease
AU2001244549A1 (en) Azure a analogues useful as probes in the diagnostic imaging for diseases due toaccumulation of amyloid and compositions for diagnostic imaging containing the analogues
PL352314A1 (en) Use of 15-deoxyspergualine for treatment of hyperreactive inflammatory diseases and autoimmunization diseases
ITMI20040989A1 (it) Uso del sulglicotide per iul trattamento delle mucositi
DE602004023635D1 (de) Angiogenesemodelle, wobei nestin-exprimierende stammzellen für das imaging von in bildung begriffenen blutgefässen verwendet werden
ITBO990038A0 (it) Pomata per la cura delle lesioni cutanee particolarmente delle ustioni .